Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study

BACKGROUND: Approximately one-third of patients with multiple sclerosis (MS) are unresponsive to, or intolerant of, interferon (IFN) therapy, prompting a switch to other disease-modifying therapies. Clinical outcomes of switching therapy are unknown. This retrospective study assessed differences in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergvall, Niklas, Makin, Charles, Lahoz, Raquel, Agashivala, Neetu, Pradhan, Ashish, Capkun, Gorana, Petrilla, Allison A., Karkare, Swapna U., McGuiness, Catherine Balderston, Korn, Jonathan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916439/
https://www.ncbi.nlm.nih.gov/pubmed/24516663
http://dx.doi.org/10.1371/journal.pone.0088472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916439/
https://www.ncbi.nlm.nih.gov/pubmed/24516663
http://dx.doi.org/10.1371/journal.pone.0088472

Ejemplares similares